Literature DB >> 2346736

Does HLA-DR predict response to specific immunosuppressive therapy in aplastic anaemia?

F P Rugman, D Ashby, J M Davies.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1990        PMID： 2346736     DOI： 10.1111/j.1365-2141.1990.tb06352.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN： 0007-1048            Impact factor:   6.998


× No keyword cloud information.
  3 in total

Review 1.  Genetics of graft-versus-host disease: the major histocompatibility complex.

Authors:  Effie W Petersdorf
Journal:  Blood Rev       Date:  2012-11-20       Impact factor: 8.250

2.  HLA DR15 antigen status does not impact graft-versus-host disease or survival in HLA-matched sibling transplantation for hematologic malignancies.

Authors:  Minoo Battiwalla; Kristin Ellis; Peigang Li; Steven Z Pavletic; Gorgun Akpek; Peiman Hematti; Thomas R Klumpp; Richard T Maziarz; Bipin N Savani; Mahmoud D Aljurf; Mitchell S Cairo; William R Drobyski; Biju George; Theresa Hahn; Nandita Khera; Mark R Litzow; Alison W Loren; Wael Saber; Mukta Arora; Alvaro Urbano-Ispizua; Corey Cutler; Mary E D Flowers; Stephen R Spellman
Journal:  Biol Blood Marrow Transplant       Date:  2012-03-10       Impact factor: 5.742

3.  HLA-DR2 Frequency Increase in Severe Aplastic Anemia Patients is Mainly Attributed to the Prevalence of DR15 Subtype.

Authors:  Sergey I Kapustin; Tamara I Popova; Anton A Lyschov; Alexander V Togo; Kudrat M Abdulkadyrov; Michail N Blinov
Journal:  Pathol Oncol Res       Date:  1997       Impact factor: 3.201
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.